Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03105336
Brief Title: A Phase 2 Multicenter Study of Axicabtagene Ciloleucel in Subjects With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma (ZUMA-5)

First Submitted : April 3, 2017
First Submitted that Met QC Criteria : April 3, 2017
First Posted : April 7, 2017

Last Update Submitted that Met QC Criteria : March 16, 2021
Last Update Posted : March 18, 2021